Scalp-Injected RNA Hair Loss Drug Completes Phase 1b Dosing in Australia
OliX announced on August 4 that it has completed patient dosing in the Australian Phase 1b clinical trial for OLX104C (compound name: OLX72021), an...
Search results for "drug treatment"
Olix Obesity Candidate Reduces Monkeys’ Visceral Fat by 29.2%, Outperforming Global Rival
Olix announced on July 30 that its obesity drug candidate, "OLX501A," significantly outperformed a global rival compound in reducing visceral fat...
Chong Kun Dang’s CKD-339 Enters Phase 3 in South Korea for Patients Uncontrolled on Monotherapy
CKD-339, an essential hypertension treatment under development by Chong Kun Dang, is advancing into a Phase 3 clinical...
ABL Bio’s Stomach Cancer Drug Shows Promise in Once 'Untreatable' Patients
South Korean platform biotech company ABL Bio announced that development remains firmly on track despite investor...
Daewoong Pharmaceutical Secures 145.2 Billion Won MENA Export Deal for Diabetes Drug Enblo
Daewoong Pharmaceutical’s proprietary type 2 diabetes treatment, Enblo (active ingredient: enavogliflozin), is set to...
Dongkook Pharmaceutical Secures 39 Billion Won Latin American Export Deal for BPH Treatment Uresco
Waking up frequently at night to urinate or noticing a weaker urine stream is a common health concern for men as they...
Diabetes Drug Repurposed: Evogliptin Shows Promise in Preventing Disfiguring Burn Scars
Burn survivors frequently face a distressing secondary complication known as hypertrophic scarring, where the skin...
"Punishment Alone Won't Stop the Express Train to Hell," Warns Addiction Expert Cheon Young-hoon
“A lot of people call drug addiction an ‘express train to hell,’ right. It is a remarkably accurate metaphor.
"A Bike Is More Thrilling Than a Syringe Now": Inside South Korea's Last-Resort Hospital Treating 90% of Hospitalized Drug Addicts
A 190-centimeter-tall man with celebrity-grade looks opened the examination room door and walked in.
New Blood Test Accurately Predicts Alzheimer’s Progression, Pinpointing Optimal Candidates for Treatment
Dementia medications do not yield uniform results for every patient; instead, their clinical efficacy depends heavily...